Princeton, New Jersey
United States
17
2020-09-24
The entities that hold a legal rights for patent applications filed by inventor Wright John Fraser:
John Fraser Wright from Princeton, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Column-based fully scalable rAAV manufacturing process
#2 | 2020-05-28ENHANCING AGENTS FOR IMPROVED CELL TRANSFECTION AND/OR rAAV VECTOR PRODUCTION
#3 | 2020-05-28APHERESIS METHODS AND USES
#4 | 2019-10-24SCALABLE MANUFACTURING PLATFORM FOR VIRAL VECTOR PURIFICATION AND VIRAL VECTORS SO PURIFIED FOR USE IN GENE THERAPY
#5 | 2019-09-26SCALABLE METHODS FOR PRODUCING RECOMBINANT ADENO-ASSOCIATED VIRAL (AAV) VECTOR IN SERUM-FREE SUSPENSION CELL CULTURE SYSTEM SUITABLE FOR CLINICAL USE
#6 | 2019-09-19SCALABLE HIGH RECOVERY METHODS FOR PRODUCING HIGH YIELD RECOMBINANT ADENO-ASSOCIATED VIRAL (rAAV) VECTOR AND RECOMBINANT ADENO-ASSOCIATED VIRAL (rAAV) VECTORS PRODUCED THEREBY
#7 | 2019-03-28Large commercial scale lentiviral vector production system and vectors produced thereby
#8 | 2019-03-14CELL LINE FOR RECOMBINANT PROTEIN AND/OR VIRAL VECTOR PRODUCTION
#9 | 2018-05-17Rab Escort Protein potency assay
#10 | 2017-12-28Scalable manufacturing process to produce recombinant lentiviral vectors in serum-free suspension cell culture system
#11 | 2017-05-11Humanized viral vectors and methods of use thereof
#12 | 2016-07-21Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy
#13 | 2014-02-06AAV8 vector with enhanced functional activity and methods of use thereof
#14 | 2013-03-21Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy
#15 | 2011-03-31Compositions and methods to prevent AAV vector aggregation
#16 | 2010-04-22Humanized Viral Vectors and Methods of Use Thereof
#17 | 2006-02-16Compositions and methods to prevent AAV vector aggregation
154532 ⎘